Welcome to LookChem.com Sign In|Join Free
  • or
Glycidic acid methyl ester, also known as Methyl Oxirane-2-carboxylate, is an organic compound that serves as an important intermediate in the synthesis of various chemicals and pharmaceuticals. It is characterized by its unique epoxide ring and ester functional group, which contribute to its reactivity and versatility in chemical reactions.

4538-50-5

Post Buying Request

4538-50-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4538-50-5 Usage

Uses

Used in Pharmaceutical Synthesis:
Glycidic acid methyl ester is used as an intermediate in the synthesis of DL-Indole-3-lactic Acid-d5 (I627102), which is the isotope-labelled analog of DL-Indole-3-lactic Acid (I627100). Glycidic acid methyl ester plays a crucial role in the development of pharmaceuticals and their isotope-labelled counterparts for research and diagnostic purposes.
Used in Antibacterial Applications:
Glycidic acid methyl ester is used as a reagent in the synthesis of 2-hydroxy-1-(1H-indol-3-yl)-4-methylpentan-3-one, a compound with weak antibacterial activity against various bacterial strains, including Escherichia coli, Bacillus subtilis, and Staphylococcus aureus. This application highlights its potential in the development of new antimicrobial agents.
Used in Sweetener Production:
Glycidic acid methyl ester is also utilized in the preparation of Monatin, a natural sweet peptidomimetic. This application demonstrates its versatility in the synthesis of compounds with diverse properties and functions, ranging from pharmaceuticals to sweeteners in the food industry.

Check Digit Verification of cas no

The CAS Registry Mumber 4538-50-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,3 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4538-50:
(6*4)+(5*5)+(4*3)+(3*8)+(2*5)+(1*0)=95
95 % 10 = 5
So 4538-50-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H6O3/c1-6-4(5)3-2-7-3/h3H,2H2,1H3

4538-50-5Synthetic route

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

methyl glycidate
4538-50-5

methyl glycidate

Conditions
ConditionsYield
With Mn-trimethyltriazacyclononane; dihydrogen peroxide; sodium L-ascorbate In water; acetonitrile at 0℃; Epoxidation;97%
With sodium hypochlorite; tetrabutyl-ammonium chloride; sodium hydrogencarbonate In water at 40℃; for 1h; Reagent/catalyst; Green chemistry;82%
With sodium hypochlorite In water at 0 - 70℃; Product distribution / selectivity;80%
methacrylic acid methyl ester
80-62-6

methacrylic acid methyl ester

methyl glycidate
4538-50-5

methyl glycidate

Conditions
ConditionsYield
With sodium hypochlorite; carbon dioxide; sodium carbonate In water at 10℃; for 1h;50%
methyl glycidate
4538-50-5

methyl glycidate

carbon dioxide
124-38-9

carbon dioxide

4-methoxycarbonyl-2-oxo-1,3-dioxolane
1352430-21-7

4-methoxycarbonyl-2-oxo-1,3-dioxolane

Conditions
ConditionsYield
With trimethylbenzylammonium bromide at 70℃; under 33753.4 - 37503.8 Torr; for 15h; Product distribution / selectivity;100%
With tert-butyl methyl ether; tetrabutylammomium bromide at 40℃; under 15001.5 Torr; for 96h; Product distribution / selectivity;94%
With tetrabutylammomium bromide In tert-butyl methyl ether at 40℃; under 15001.5 Torr; for 96h; Reagent/catalyst; Sealed tube;94%
methyl glycidate
4538-50-5

methyl glycidate

4-methoxy-benzylamine
2393-23-9

4-methoxy-benzylamine

2-hydroxy-N-(4-methoxybenzyl)-3-(4-methoxybenzylamino)propionamide
1099828-11-1

2-hydroxy-N-(4-methoxybenzyl)-3-(4-methoxybenzylamino)propionamide

Conditions
ConditionsYield
at 60℃; for 6h; Inert atmosphere;99%
methyl glycidate
4538-50-5

methyl glycidate

phenol
108-95-2

phenol

(R)-2-Hydroxy-3-phenoxy-propionic acid methyl ester
233770-36-0

(R)-2-Hydroxy-3-phenoxy-propionic acid methyl ester

Conditions
ConditionsYield
With (R,R)-(salen)Co(H2O); 3 A molecular sieve In various solvent(s) at -20℃;98%
chiral Co-complex
methyl glycidate
4538-50-5

methyl glycidate

1,1-dimethylhydrazine
57-14-7

1,1-dimethylhydrazine

4-hydroxy-1,1-dimethyl-pyrazolidin-3-one

4-hydroxy-1,1-dimethyl-pyrazolidin-3-one

Conditions
ConditionsYield
In isopropyl alcohol at 20℃; for 3h;95%
methyl glycidate
4538-50-5

methyl glycidate

o-bromobenzyl alcohol
18982-54-2

o-bromobenzyl alcohol

(2R)-3-(2-bromobenzyloxy)-2-hydroxypropionic acid methyl ester
1612884-62-4

(2R)-3-(2-bromobenzyloxy)-2-hydroxypropionic acid methyl ester

Conditions
ConditionsYield
In acetonitrile at 4℃; for 24h; enantioselective reaction;94%
7,8-benzoquinoline
230-27-3

7,8-benzoquinoline

methyl glycidate
4538-50-5

methyl glycidate

methyl 3-(benzo[h]quinolin-10-yl)-2-hydroxypropanoate

methyl 3-(benzo[h]quinolin-10-yl)-2-hydroxypropanoate

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol; palladium diacetate; acetic acid at 25℃; for 24h; Inert atmosphere;92%
methyl glycidate
4538-50-5

methyl glycidate

diethyl[(trimethylsilyl)acetylenyl]aluminum
82731-79-1

diethyl[(trimethylsilyl)acetylenyl]aluminum

C9H16O3Si

C9H16O3Si

Conditions
ConditionsYield
In toluene at 0℃;90%
methyl glycidate
4538-50-5

methyl glycidate

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

Conditions
ConditionsYield
With sodium iodide; tin(ll) chloride In ethanol for 0.05h; Reflux; Green chemistry;85%
methyl glycidate
4538-50-5

methyl glycidate

3-butyl-3-ethyl-5-(4-fluorophenyl)-8-hydroxy-7-(methylthio)-2,3,4,5-tetrahydro-1,5-benzothiazepine 1,1-dioxide

3-butyl-3-ethyl-5-(4-fluorophenyl)-8-hydroxy-7-(methylthio)-2,3,4,5-tetrahydro-1,5-benzothiazepine 1,1-dioxide

methyl 3-((3-butyl-3-ethyl-5-(4-fluorophenyl)-7-(methylthio)-1,1-dioxido-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-hydroxypropanoate

methyl 3-((3-butyl-3-ethyl-5-(4-fluorophenyl)-7-(methylthio)-1,1-dioxido-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-hydroxypropanoate

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20 - 25℃; for 16h;82%
methyl glycidate
4538-50-5

methyl glycidate

benzyllithium
766-04-1

benzyllithium

1-(oxiran-2-yl)-2-phenylethanone
1174507-66-4

1-(oxiran-2-yl)-2-phenylethanone

Conditions
ConditionsYield
In tetrahydrofuran; toluene at -85℃; for 1.58333h; Inert atmosphere;81%
methyl glycidate
4538-50-5

methyl glycidate

2-chloro-6-methylphenol
87-64-9

2-chloro-6-methylphenol

(2R)-3-(2-chloro-6-methylphenoxy)-2-hydroxypropionic acid methyl ester
1612884-59-9

(2R)-3-(2-chloro-6-methylphenoxy)-2-hydroxypropionic acid methyl ester

Conditions
ConditionsYield
In acetonitrile at 23℃; for 24h; enantioselective reaction;80%
methyl glycidate
4538-50-5

methyl glycidate

acetyl chloride
75-36-5

acetyl chloride

methyl 2-acetoxy-3-chloropropionate
78626-45-6

methyl 2-acetoxy-3-chloropropionate

Conditions
ConditionsYield
With hydrogenchloride; zinc(II) chloride In benzene at 10℃; for 0.5h;78%
methyl glycidate
4538-50-5

methyl glycidate

1-phenylisoquinoline
3297-72-1

1-phenylisoquinoline

methyl 2-hydroxy-3-(2-(isoquinolin-1-yl)phenyl)propanoate

methyl 2-hydroxy-3-(2-(isoquinolin-1-yl)phenyl)propanoate

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol; palladium diacetate; acetic acid at 25℃; for 24h; Inert atmosphere;78%
methyl glycidate
4538-50-5

methyl glycidate

m-Toluic acid
99-04-7

m-Toluic acid

methyl 7-methyl-1-oxoisochroman-3-carboxylate
890646-70-5

methyl 7-methyl-1-oxoisochroman-3-carboxylate

Conditions
ConditionsYield
With potassium acetate; palladium diacetate; (S)-2-acetylamino-3,3-dimethylbutyric acid at 75℃; for 24h; Sealed tube;72%
methyl glycidate
4538-50-5

methyl glycidate

p-benzyloxyaniline
6373-46-2

p-benzyloxyaniline

methyl 2-hydroxy-3-[(4'-benzyloxyphenyl)amino]propanoate

methyl 2-hydroxy-3-[(4'-benzyloxyphenyl)amino]propanoate

Conditions
ConditionsYield
In methanol for 6h; Heating;71%
methyl glycidate
4538-50-5

methyl glycidate

1-Aminopiperidine
2213-43-6

1-Aminopiperidine

3-hydroxy-1,5-diaza-spiro[4.5]decan-2-one

3-hydroxy-1,5-diaza-spiro[4.5]decan-2-one

Conditions
ConditionsYield
In isopropyl alcohol at 20℃; for 5h;71%
methyl glycidate
4538-50-5

methyl glycidate

(E)-acetophenone O-methyloxime
15754-20-8

(E)-acetophenone O-methyloxime

(E)-methyl 2-hydroxy-3-(2-(1-(methoxyimino)ethyl)phenyl)propanoate

(E)-methyl 2-hydroxy-3-(2-(1-(methoxyimino)ethyl)phenyl)propanoate

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol; palladium diacetate; acetic acid at 25℃; for 24h; Inert atmosphere;71%
methyl glycidate
4538-50-5

methyl glycidate

7-amino-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one
862470-02-8

7-amino-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one

ethyl 2-hydroxy-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-ylamino]propanoate
908256-56-4

ethyl 2-hydroxy-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-ylamino]propanoate

Conditions
ConditionsYield
In ethanol for 96h; Heating / reflux;70%
methyl glycidate
4538-50-5

methyl glycidate

N-methoxy-4-methylbenzamide
25563-06-8

N-methoxy-4-methylbenzamide

methyl 6-methyl-1-oxoisochroman-3-carboxylate

methyl 6-methyl-1-oxoisochroman-3-carboxylate

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol; palladium diacetate; acetic acid at 25℃; for 36h; Inert atmosphere;68%
methyl glycidate
4538-50-5

methyl glycidate

N-(2-methylbenzoyl)-8-aminoquinoline
1182669-71-1

N-(2-methylbenzoyl)-8-aminoquinoline

methyl 2-hydroxy-3-(3-methyl-2-(quinolin-8-ylcarbamoyl)phenyl)propanoate

methyl 2-hydroxy-3-(3-methyl-2-(quinolin-8-ylcarbamoyl)phenyl)propanoate

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol; palladium diacetate; acetic acid at 25℃; for 24h; Inert atmosphere;67%
methyl glycidate
4538-50-5

methyl glycidate

phenyl isocyanate
103-71-9

phenyl isocyanate

phenylacetylene
536-74-3

phenylacetylene

methyl 6‐benzylidene‐5‐oxo‐4‐phenylmorpholine‐2‐carboxylate

methyl 6‐benzylidene‐5‐oxo‐4‐phenylmorpholine‐2‐carboxylate

Conditions
ConditionsYield
Stage #1: phenyl isocyanate; phenylacetylene With copper(l) iodide; potassium tert-butylate In 1,4-dioxane at 105℃; for 1h; Inert atmosphere; Molecular sieve;
Stage #2: methyl glycidate In 1,4-dioxane at 105℃; for 18h; Inert atmosphere; Molecular sieve; regioselective reaction;
64%
methyl glycidate
4538-50-5

methyl glycidate

aniline
62-53-3

aniline

methyl 2-hydroxy-3-(phenylamino)propanoate

methyl 2-hydroxy-3-(phenylamino)propanoate

Conditions
ConditionsYield
In methanol for 2h; Heating;60%
methyl glycidate
4538-50-5

methyl glycidate

3-butyl-3-ethyl-8-hydroxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine 1,1-dioxide
358376-02-0

3-butyl-3-ethyl-8-hydroxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine 1,1-dioxide

methyl 3-((3-butyl-3-ethyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-hydroxypropanoate

methyl 3-((3-butyl-3-ethyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-hydroxypropanoate

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20 - 25℃; for 16h;60%
methyl glycidate
4538-50-5

methyl glycidate

3-(trifluoroacetyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7-amine
163068-05-1

3-(trifluoroacetyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7-amine

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

C17H17F3N2O5

C17H17F3N2O5

Conditions
ConditionsYield
With lithium trifluoromethanesulfonate54%
methyl glycidate
4538-50-5

methyl glycidate

1-(4-hydroxyphenyl)ethanone O-(4-(trifluoromethyl)benzyl)oxime

1-(4-hydroxyphenyl)ethanone O-(4-(trifluoromethyl)benzyl)oxime

methyl 2-hydroxy-3-(4-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)ethyl)phenoxy)propanoate

methyl 2-hydroxy-3-(4-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)ethyl)phenoxy)propanoate

Conditions
ConditionsYield
With dmap at 120℃; for 8h;52.6%
1-aminomorpholine
4319-49-7

1-aminomorpholine

methyl glycidate
4538-50-5

methyl glycidate

3-hydroxy-8-oxa-1,5-diazaspiro[4.5]decan-2-one

3-hydroxy-8-oxa-1,5-diazaspiro[4.5]decan-2-one

Conditions
ConditionsYield
In isopropyl alcohol at 20℃; for 5h;49%
methyl glycidate
4538-50-5

methyl glycidate

7-amino-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one
862470-02-8

7-amino-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one

methyl 2-hydroxy-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-ylamino]propionate

methyl 2-hydroxy-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-ylamino]propionate

Conditions
ConditionsYield
In methanol at 70℃; for 14h;48%
N-amino-N'-methylpiperazine
6928-85-4

N-amino-N'-methylpiperazine

methyl glycidate
4538-50-5

methyl glycidate

3-hydroxy-8-methyl-1,5,8-triaza-spiro[4.5]decan-2-one

3-hydroxy-8-methyl-1,5,8-triaza-spiro[4.5]decan-2-one

Conditions
ConditionsYield
In isopropyl alcohol at 20℃; for 4h;45%

4538-50-5Relevant academic research and scientific papers

Synthesis of (±)-eusynstyelamide A

Barykina, Olga V.,Snider, Barry B.

, p. 2664 - 2667 (2010)

The synthesis of (±)-eusynstyelamide A has been accomplished in six steps in 13% overall yield from 6-bromoindole, methyl glycidate, and Boc-protected agmatine. If oxygen is carefully excluded from the reaction, the key NaOH-catalyzed aldol dimerization of the α-ketoamide proceeded efficiently to give Boc-protected eusynstyelamide A.

Facile synthesis of glycidates via oxidation of acrylates with aqueous solution of naocl in the presence of ammonium salts

Ochiai, Bungo,Hirano, Taiki

, p. 487 - 493 (2014)

Various glycidates were obtained in high yields via green oxidation of acrylates with aqueous solution of NaOCl in the presence of ammonium salts. The appropriate choice of ammonium salts fitting to the polarity of the substrates and the reaction under slightly basic conditions were essential for efficient reactions.

Synthesis of the fungal macrolide berkeleylactone A and its inhibition of microbial biofilm formation

Schobert, Rainer,Schrey, Hedda,Schriefer, Manuel G.,Stadler, Marc,Zeng, Haoxuan

, p. 4743 - 4751 (2021/06/11)

The fungal macrolide berkeleylactone A was synthesised in 13 steps and 24% yield using (R)-propylene oxide and an asymmetric Noyori hydrogenation of a β-ketoester to install the stereogenic centres. A domino addition-Wittig olefination of a 13-hydroxytetradecanal intermediate with the cumulated ylide Ph3PCCO closed the macrocyle by establishing the α,β-unsaturated ester group, necessary for the attachment of the sidechain thiol via a thia-Michael reaction. The synthetic berkeleylactone A inhibited the formation of Staphylococcus aureus biofilms and showed significant dispersive effects on preformed biofilms of Candida albicans by at least 45% relative to untreated controls at concentrations as low as 1.3 μg mL-1.

Aromatic Donor-Acceptor Interaction-Based Co(III)-salen Self-Assemblies and Their Applications in Asymmetric Ring Opening of Epoxides

Liang, Jian,Soucie, Luke N.,Blechschmidt, Daniel R.,Yoder, Aaron,Gustafson, Addie,Liu, Yu

supporting information, p. 513 - 518 (2019/01/14)

Aromatic donor-acceptor interaction as the driving force to assemble cooperative catalysts is described. Pyrene/naphthalenediimide functionalized Co(III)-salen complexes self-assembled into bimetallic catalysts through aromatic donor-acceptor interactions and showed high catalytic activity and selectivity in the asymmetric ring opening of various epoxides. Control experiments, nuclear magnetic resonance (NMR) spectroscopy titrations, mass spectrometry measurement, and X-ray crystal structure analysis confirmed that the catalysts assembled based on the aromatic donor-acceptor interaction, which can be a valuable noncovalent interaction in supramolecular catalyst development.

Poly(Alkyl Glycidate Carbonate)s as Degradable Pressure-Sensitive Adhesives

Beharaj, Anjeza,Ekladious, Iriny,Grinstaff, Mark W.

supporting information, p. 1407 - 1411 (2019/01/14)

Insertion of CO2 into the polyacrylate backbone, forming poly(carbonate) analogues, provides an environmentally friendly and biocompatible alternative. The synthesis of five poly(carbonate) analogues of poly(methyl acrylate), poly(ethyl acrylate), and poly(butyl acrylate) is described. The polymers are prepared using the salen cobalt(III) complex catalyzed copolymerization of CO2 and a derivatized oxirane. All the carbonate analogues possess higher glass-transition temperatures (Tg=32 to ?5 °C) than alkyl acrylates (Tg=10 to ?50 °C), however, the carbonate analogues (Td≈230 °C) undergo thermal decomposition at lower temperatures than their acrylate counterparts (Td≈380 °C). The poly(alkyl carbonates) exhibit compositional-dependent adhesivity. The poly(carbonate) analogues degrade into glycerol, alcohol, and CO2 in a time- and pH-dependent manner with the rate of degradation accelerated at higher pH conditions, in contrast to poly(acrylate)s.

The asymmetric total synthesis of (+)-salvianolic acid A

Zheng, Yong,Song, Wei-Bin,Xuan, Li-Jiang

supporting information, p. 5047 - 5050 (2016/07/25)

An asymmetric synthesis of (+)-salvianolic acid A with cardioprotective properties, has been accomplished in a convergent manner in eight steps and 10.6% overall yield. This synthesis features an asymmetric addition of organometallics to optically pure 2,3-epoxypropionate in the presence of BF3·Et2O, Ru(III)-catalyzed directed [Formula presented] olefination, and I2-catalyzed isomerization reaction.

NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE

-

Page/Page column 195; 196, (2016/10/04)

A compound of Formula I is provided: or pharmaceutically acceptable enantiomers, salts or solvates thereof. The 5 invention further relates to the use of the compounds of Formula I as TDO2 inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer, neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease, chronic viral infections such as HCV and HIV, depression, and obesity. The invention also 10 relates to a process for manufacturing compounds of Formula I.

Epoxide manufacturing method

-

Paragraph 0049-0056, (2016/10/20)

Method for producing epoxides of formula (I), where R stands for an organic group with 1-10 C atoms, by reaction of compounds of formula (II) with an oxidation agent, characterized in that the production takes place continuously in a tube reactor.

Α coccidiosis production of acrylic acid ester

-

Paragraph 0048, (2016/12/16)

PROBLEM TO BE SOLVED: To provide a production method with which α-acyloxy acrylate can be obtained at high yield using commodity chemicals as raw materials and which is thereby suitable to be used industrially as a method for producing the α-acyloxy acrylate. SOLUTION: The method for producing the α-acyloxy acrylate includes a process for obtaining the α-acyloxy acrylate, which has a specific structure, using glycidic esters that have a specific structure. COPYRIGHT: (C)2012,JPOandINPIT

A broadly applicable and practical oligomeric (salen)Co catalyst for enantioselective epoxide ring-opening reactions

White, David E.,Tadross, Pamela M.,Lu, Zhe,Jacobsen, Eric N.

supporting information, p. 4165 - 4180 (2014/06/09)

The (salen)Co catalyst (4a) can be prepared as a mixture of cyclic oligomers in a short, chromatography-free synthesis from inexpensive, commercially available precursors. This catalyst displays remarkable enhancements in reactivity and enantioselectivity relative to monomeric and other multimeric (salen)Co catalysts in a wide variety of enantioselective epoxide ring-opening reactions. The application of catalyst 4a is illustrated in the kinetic resolution of terminal epoxides by nucleophilic ring-opening with water, phenols, and primary alcohols; the desymmetrization of meso epoxides by addition of water and carbamates; and the desymmetrization of oxetanes by intramolecular ring opening with alcohols and phenols. The favorable solubility properties of complex 4a under the catalytic conditions facilitated mechanistic studies, allowing elucidation of the basis for the beneficial effect of oligomerization. Finally, a catalyst selection guide is provided to delineate the specific advantages of oligomeric catalyst 4a relative to (salen)Co monomer 1 for each reaction class.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4538-50-5